NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/13/2025
Back to search
Official data from USPTO
LABCORP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000090687165Class
10, 35, 42, 44
Filing
90687165
Registration
7795684
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
05/13/2025
Trademark type
Combined
Nice classes
10, 35, 42, 44
Filing date
05/03/2021
Registration date
05/13/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2025
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
01/02/2021
First use in commerce
01/02/2021
Drawing code
3
Owner type
03
Owner location
Burlington, NC
Examiner
MCBRIDE, CAMERON L
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three concentric circles in azure, cerulean and turquoise followed by the term "labcorp" in lower case bold black letters.
Holders and representatives
Holders
Laboratory Corporation of America Holdings
Representatives
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Diagnostic test kits for medical use comprised of devices for collecting bodily fluid samplescollection tubeslancetsswabsprobes and collection envelopesall for the purpose of medical diagnostic testing and treatment
Class 35
Business management and management consulting services in connection with the provision of clinicaldiagnostic and analytical testing services; regulatory submission managementassisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting of drug supplies for clinical trials; recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; market researchdata collection into computer databasesdatabase managementbusiness project management servicesall in the fields of medical testingdiagnostic testingtesting for forensic purposestesting for quality control purposesgenetic testingclinical and analytical testingdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology
Class 42
pharmaceutical drug development and testing services; research and development of pharmaceuticalsmedical devicesbiotechnologybiochemical; medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of conducting clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; providing online computer databases featuring information in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemical; providing temporary use of non-downloadable software through a web-based portal to collectorganizereport medical informationmedical recordsdiagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposestesting for quality control purposesgenetic testing for scientific research purposesmedical and scientific research in the field ofdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; temporary computer information storage and retrieval in the field of clinicaldiagnostic and analytical testing
Class 44
medical testing for diagnostictreatmentscreening purposes; medical testing for forensic diagnostic purposes; genetic testing for medical purposes; consulting services in the fields of medical testinggenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical care and healthcare
Publications
History of USPTO decisions and trademark events.
54 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/13/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2025
ALIE
ASSIGNED TO LIE
04/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2025
GNRT
NON-FINAL ACTION E-MAILED
01/06/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/18/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/17/2024
IUAF
USE AMENDMENT FILED
10/04/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2024
EX3G
SOU EXTENSION 3 GRANTED
10/04/2024
EXT3
SOU EXTENSION 3 FILED
10/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/03/2024
EX2G
SOU EXTENSION 2 GRANTED
04/02/2024
EXT2
SOU EXTENSION 2 FILED
04/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/05/2023
EX1G
SOU EXTENSION 1 GRANTED
10/03/2023
EXT1
SOU EXTENSION 1 FILED
10/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2023
PUBO
PUBLISHED FOR OPPOSITION
02/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/11/2022
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
11/28/2022
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
11/28/2022
CNCF
ACTION CONTINUING A FINAL - COMPLETED
11/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/08/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/12/2022
GNFR
FINAL REFUSAL E-MAILED
05/12/2022
CNFR
FINAL REFUSAL WRITTEN
05/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/27/2021
GNRT
NON-FINAL ACTION E-MAILED
10/27/2021
CNRT
NON-FINAL ACTION WRITTEN
10/27/2021
DOCK
ASSIGNED TO EXAMINER
10/20/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2021
NWAP
NEW APPLICATION ENTERED
05/06/2021
Continuous trademark protection
Get notified about every new filing that threatens LABCORP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.